nquery advisor software (SOPHARMA Inc)
90
Structured Review
SOPHARMA Inc
nquery advisor software
West 2011 " width="250" height="auto" />
Nquery Advisor Software, supplied by SOPHARMA Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nquery+advisor+software/nquery+advisor+software/pmc10303407-1076-26-14
Average 90 stars, based on 1 article reviews
West 2011 " width="250" height="auto" />Nquery Advisor Software, supplied by SOPHARMA Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nquery+advisor+software/nquery+advisor+software/pmc10303407-1076-26-14
Average 90 stars, based on 1 article reviews
nquery advisor software - by Bioz Stars,
2026-10
90/100 stars
Images
1) Product Images from "Nicotine receptor partial agonists for smoking cessation"
Article Title: Nicotine receptor partial agonists for smoking cessation
Journal: The Cochrane Database of Systematic Reviews
doi: 10.1002/14651858.CD006103.pub9
West 2011 " title=" West 2011 " property="contentUrl" width="100%" height="100%"/>
Figure Legend Snippet:
Techniques Used: Biomarker Discovery, Sequencing, Selection, Generated, Software, Blocking Assay
Related Articles
Sequencing:Article Title: Nicotine receptor partial agonists for smoking cessation Article Snippet: .. Random sequence generation (selection bias) , Low risk , "performed by a statistician at Sopharma, who generated a list of study‐group assignments for 740 participants with Article Title: Nicotine receptor partial agonists for smoking cessation Article Snippet: .. Bias Authors’ judgement Support for judgement Random sequence generation (selection bias) Low risk “performed by a statistician at Sopharma, who generated a list of study-group assignments for 740 participants with Article Title: Nicotine receptor partial agonists for smoking cessation Article Snippet: .. Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk "performed by a statistician at Sopharma, who generated a list of study-group assignments for 740 participants with Selection:Article Title: Nicotine receptor partial agonists for smoking cessation Article Snippet: .. Random sequence generation (selection bias) , Low risk , "performed by a statistician at Sopharma, who generated a list of study‐group assignments for 740 participants with Article Title: Nicotine receptor partial agonists for smoking cessation Article Snippet: .. Bias Authors’ judgement Support for judgement Random sequence generation (selection bias) Low risk “performed by a statistician at Sopharma, who generated a list of study-group assignments for 740 participants with Article Title: Nicotine receptor partial agonists for smoking cessation Article Snippet: .. Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk "performed by a statistician at Sopharma, who generated a list of study-group assignments for 740 participants with Generated:Article Title: Nicotine receptor partial agonists for smoking cessation Article Snippet: .. Random sequence generation (selection bias) , Low risk , "performed by a statistician at Sopharma, who generated a list of study‐group assignments for 740 participants with Article Title: Nicotine receptor partial agonists for smoking cessation Article Snippet: .. Bias Authors’ judgement Support for judgement Random sequence generation (selection bias) Low risk “performed by a statistician at Sopharma, who generated a list of study-group assignments for 740 participants with Article Title: Nicotine receptor partial agonists for smoking cessation Article Snippet: .. Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk "performed by a statistician at Sopharma, who generated a list of study-group assignments for 740 participants with Article Title: Placebo-Controlled Trial of Cytisine for Smoking Cessation Article Snippet: From the Cancer Research UK Health Behaviour Research Centre, Department of Epidemiology and Public Health, University College London, London (R.W., J.S.); the Cancer Center and Institute of Oncology, Cancer Epidemiology and Prevention Department, Warsaw, Poland (W.Z., M.C., D.L., J.P.); and the UK Centre for Tobacco Control Studies, Primary Care Clinical Sciences, University of Birmingham, Birmingham, United Kingdom (P.A.).. Address reprint requests to Dr. West at the Department of Epidemiology and Public Health, University College London, 2-16 Torrington Pl., London WC1E 6BT, United Kingdom, or at robert.west@ucl.ac.uk, or to Dr. Zatonski at the Cancer Center and Institute of Oncology, Cancer Epidemiology and Prevention Department, 5 Roentgen St., 02-781 Warsaw, Poland. Software:Article Title: Nicotine receptor partial agonists for smoking cessation Article Snippet: .. Random sequence generation (selection bias) , Low risk , "performed by a statistician at Sopharma, who generated a list of study‐group assignments for 740 participants with Article Title: Nicotine receptor partial agonists for smoking cessation Article Snippet: .. Bias Authors’ judgement Support for judgement Random sequence generation (selection bias) Low risk “performed by a statistician at Sopharma, who generated a list of study-group assignments for 740 participants with Article Title: Nicotine receptor partial agonists for smoking cessation Article Snippet: .. Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk "performed by a statistician at Sopharma, who generated a list of study-group assignments for 740 participants with Article Title: Placebo-Controlled Trial of Cytisine for Smoking Cessation Article Snippet: From the Cancer Research UK Health Behaviour Research Centre, Department of Epidemiology and Public Health, University College London, London (R.W., J.S.); the Cancer Center and Institute of Oncology, Cancer Epidemiology and Prevention Department, Warsaw, Poland (W.Z., M.C., D.L., J.P.); and the UK Centre for Tobacco Control Studies, Primary Care Clinical Sciences, University of Birmingham, Birmingham, United Kingdom (P.A.).. Address reprint requests to Dr. West at the Department of Epidemiology and Public Health, University College London, 2-16 Torrington Pl., London WC1E 6BT, United Kingdom, or at robert.west@ucl.ac.uk, or to Dr. Zatonski at the Cancer Center and Institute of Oncology, Cancer Epidemiology and Prevention Department, 5 Roentgen St., 02-781 Warsaw, Poland. Blocking Assay:Article Title: Nicotine receptor partial agonists for smoking cessation Article Snippet: .. Random sequence generation (selection bias) , Low risk , "performed by a statistician at Sopharma, who generated a list of study‐group assignments for 740 participants with |